Sector
HealthcareOpen
₹75.01Prev. Close
₹76.06Turnover(Lac.)
₹10.59Day's High
₹76.43Day's Low
₹74.6752 Week's High
₹11152 Week's Low
₹48.5Book Value
₹28.86Face Value
₹10Mkt Cap (₹ Cr.)
155.33P/E
72.88EPS
1.04Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 20.8 | 20.8 | 20.8 | 20.8 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 38.61 | 36.78 | 33.81 | 31.9 |
Net Worth | 59.41 | 57.58 | 54.61 | 52.7 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 32.36 | 40.55 | 38.02 | 33.96 |
yoy growth (%) | -20.18 | 6.65 | 11.94 | 9.09 |
Raw materials | -9.76 | -11.86 | -11.01 | -10.91 |
As % of sales | 30.16 | 29.25 | 28.97 | 32.14 |
Employee costs | -6.97 | -8.93 | -8.66 | -7.46 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 1.91 | 2.14 | 1.66 | 0.45 |
Depreciation | -2.33 | -2.49 | -3.37 | -3.44 |
Tax paid | -0.42 | -0.39 | 0.04 | 0.02 |
Working capital | 3.08 | 3.66 | -1.44 | 0.83 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -20.18 | 6.65 | 11.94 | 9.09 |
Op profit growth | -6.58 | -9.62 | 30.18 | -17.18 |
EBIT growth | -10.93 | 29.45 | 232.88 | 862.24 |
Net profit growth | 47.28 | -39.05 | 293.4 | 340.47 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 7,031.35 | 96.56 | 1,01,194.2 | 251.7 | 0.23 | 1,936.6 | 536.28 |
Max Healthcare Institute Ltd MAXHEALTH | 931 | 126.61 | 90,588.13 | 154.14 | 0.16 | 621.39 | 79.01 |
Fortis Healthcare Ltd FORTIS | 596.85 | 341 | 45,052.13 | 26.83 | 0.17 | 333.4 | 120.36 |
Syngene International Ltd SYNGENE | 938.2 | 83.92 | 37,768.03 | 73.9 | 0.13 | 726.5 | 104.14 |
Global Health Ltd MEDANTA | 1,131.5 | 81.87 | 30,363.31 | 96.28 | 0 | 611.45 | 106.08 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Director
D R Kaarthikeyan
Independent Director
S S Badrinath
Independent Director
Yogesh Shah
Independent Director
M Alagiriswamy
Managing Director
Sangeetha Sundaramoorthy
Chairman
Kaveetha Sundaramoorthy
Additional Director
S Natesan
Additional Director
K S Ramalaingam
Company Secretary
M Achuth menon,
Additional Director
Karthik Veeramani
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Lotus Eye Hospital & Institute Ltd
Summary
Lotus Eye Hospital & Institute Ltd, a trust hospital, was originally incorporated as Kalaivani Health Centre Pvt. Limited on 14 March, 1997. The name of the Company was changed to Lotus Eye Care Hospital Pvt. Limited on 23 January, 2006 and later on, the Company was converted into a Public Limited Company on October 16, 2007 and subsequently, the name was changed to Lotus Eye Hospital & Institute Limited on April 12, 2013. Dr S.K.Sundaramoorthy promoted the Company.Lotus Eye Care Hospital is the state of art eye care hospital group successfully functioning in South India with specialization in super-specialty service related to eye care. The Company is engaged in the field of Ophthalmology (Eye) and its related operation. It has 7 centres at Peelamedu, R.S. Puram, Mettupalayam, Tirupur, Salem, Cochin and Mulanthuruthy. Lotus has two centers in Coimbatore, one in down town and another in civil aerodrome inaugurated in the year 2002. The Salem Center is located in the heart of the city and it was started in the year 2004. The Tirupur Center started in 2007 is also functioning in prime location in the city. These hospitals have hi-tech eye care equipments and ophthalmic experts backed by well-trained paramedical and administrative team. All the centers have fully computerized modern setup manned by medical and administrative staff. The network of eye care hospitals has 9 operation theatres and 3 Lasik laser equipments. Most of the eye operations are performed as a day care proc
Read More
The Lotus Eye Hospital & Institute Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹74.68 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Lotus Eye Hospital & Institute Ltd is ₹155.33 Cr. as of 17 Sep ‘24
The PE and PB ratios of Lotus Eye Hospital & Institute Ltd is 72.88 and 2.65 as of 17 Sep ‘24
The 52-week high/low is the highest and lowest price at which a Lotus Eye Hospital & Institute Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Lotus Eye Hospital & Institute Ltd is ₹48.5 and ₹111 as of 17 Sep ‘24
Lotus Eye Hospital & Institute Ltd's CAGR for 5 Years at 27.02%, 3 Years at 16.62%, 1 Year at -10.62%, 6 Month at 21.31%, 3 Month at 23.17% and 1 Month at 5.16%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice